Angela Inzerillo, MD
Endocrinology, Diabetes & Metabolism Physician in Princeton, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Angela Inzerillo, MD filed 2,556 Medicare Part D claims in 2023 as an Endocrinology, Diabetes & Metabolism Physician in Princeton, New Jersey, prescribing 47% generic.
- 3K
- Part D claims, 2023
- 47%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥87th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1346300852 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1346300852
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- RX-MID 2,556
- BOOK-THIN 324 in New Jersey
- PHOTO-ENUM Brian Kim · 2006
Angela Inzerillo, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
2,556 ≥ 87th percentile 87% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Angela Inzerillo, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Angela Inzerillo, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New Jersey
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New Jersey providers
Endocrinology, Diabetes & Metabolism Physician ranks #73 among New Jersey's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the New Jersey provider total, by primary NUCC taxonomy. The highlighted bar is Endocrinology, Diabetes & Metabolism Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1346300852 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 12/12/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Angela Inzerillo, MD's current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1346300852 is the unique 10-digit identifier CMS uses to link Inzerillo across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Angela Inzerillo, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Angela Inzerillo, MD. Source: openpaymentsdata.cms.gov.
Total received
$3.0K
Largest payer
Boehringer Ingelheim Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
48% brand-name claims vs 47% generic, on 2,556 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 6,560
- Total Day Supply
- 195,327
- Brand vs Generic
- 48% brand / 47% generic
- Brand Drug Cost
- $1.2M
- Generic Drug Cost
- $41K
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 1.32
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 26, 65-74: 171, 75-84: 110, 85+: 31
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Angela Inzerillo, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
324 claims
- Synthroid
Synthroid
260 claims
- Glimepiride
Glimepiride
172 claims
- Metformin Hcl Er
Metformin Hcl Er
168 claims
- Jardiance 118
Jardiance
118 claims
- Rosuvastatin Calcium 96
Rosuvastatin Calcium
96 claims
- Metformin Hcl 86
Metformin Hcl
86 claims
- Mounjaro 65
Mounjaro
65 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 324 |
| Synthroid Levothyroxine Sodium | 260 |
| Glimepiride | 172 |
| Metformin Hcl Er Metformin Hcl | 168 |
| Jardiance Empagliflozin | 118 |
| Rosuvastatin Calcium | 96 |
| Metformin Hcl | 86 |
| Mounjaro Tirzepatide | 65 |
| Trulicity Dulaglutide | 51 |
| Atorvastatin Calcium | 50 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How Angela Inzerillo, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
Angela Inzerillo, MD's 2,556 claims are below the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Inzerillo, both outside New Jersey so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Inzerillo.
One of 324 Endocrinology, Diabetes & Metabolism Physician providers enrolled in New Jersey, 5 are shown here.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Angela Inzerillo, MD's specialty? ▼
How much does Angela Inzerillo, MD prescribe under Medicare Part D? ▼
Where is Angela Inzerillo, MD located? ▼
What is Angela Inzerillo, MD's NPI number? ▼
Does Angela Inzerillo, MD prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does Angela Inzerillo, MD prescribe most often? ▼
Does Angela Inzerillo, MD accept Medicare? ▼
How can I verify Angela Inzerillo, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.